144 related articles for article (PubMed ID: 12115528)
1. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma.
Ahn EY; Pan G; Vickers SM; McDonald JM
Int J Cancer; 2002 Aug; 100(4):445-51. PubMed ID: 12115528
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma).
Vickers SM; Jhala NC; Ahn EY; McDonald JM; Pan G; Bland KI
Ann Surg; 2002 Jun; 235(6):872-8. PubMed ID: 12035045
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
[TBL] [Abstract][Full Text] [Related]
4. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
5. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.
Ruiz-Ruiz C; López-Rivas A
Biochem J; 2002 Aug; 365(Pt 3):825-32. PubMed ID: 11936954
[TBL] [Abstract][Full Text] [Related]
8. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
Murphy KM; Streips UN; Lock RB
Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
10. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.
Ahn EY; Pan G; Oh JH; Tytler EM; McDonald JM
Am J Pathol; 2003 Nov; 163(5):2053-63. PubMed ID: 14578204
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
Ruiz-Ruiz C; Muñoz-Pinedo C; López-Rivas A
Cancer Res; 2000 Oct; 60(20):5673-80. PubMed ID: 11059759
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
[TBL] [Abstract][Full Text] [Related]
14. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
[TBL] [Abstract][Full Text] [Related]
15. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
Pan G; Vickers SM; Pickens A; Phillips JO; Ying W; Thompson JA; Siegal GP; McDonald JM
Am J Pathol; 1999 Jul; 155(1):193-203. PubMed ID: 10393851
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis.
Fluhr H; Krenzer S; Stein GM; Stork B; Deperschmidt M; Wallwiener D; Wesselborg S; Zygmunt M; Licht P
J Cell Sci; 2007 Dec; 120(Pt 23):4126-33. PubMed ID: 18003704
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells.
Han J; Goldstein LA; Gastman BR; Rabinovitz A; Wang GQ; Fang B; Rabinowich H
Leukemia; 2004 Oct; 18(10):1671-80. PubMed ID: 15356645
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas apoptosis in Burkitt's lymphomas with loss of multiple pro-apoptotic proteins.
Hussain A; Doucet JP; Gutiérrez M; Ahmad M; Al-Hussein K; Capello D; Gaidano G; Bhatia K
Haematologica; 2003 Feb; 88(2):167-75. PubMed ID: 12604406
[TBL] [Abstract][Full Text] [Related]
20. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
